Verastem Aktie
WKN DE: A1JTPU / ISIN: US92337C1045
|
15.01.2025 14:18:06
|
Verastem Oncology Appoints Matthew Ros As COO, Stock Up In Pre-Market
(RTTNews) - Verastem Inc. (VSTM), doing business as Verastem Oncology, Wednesday announced the appointment of Matthew Ros as chief operating officer.
Previously, Ros had served as chief executive officer and board director at FORE Biotherapeutics, an oncology company.
In the pre-market hours, Verastem's stock is climbing 4.13 percent, to $5.25 on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Verastem Incmehr Nachrichten
| Keine Nachrichten verfügbar. |